Diclofenac Sodium
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Ankle Sprain
Conditions
Acute Ankle Sprain
Trial Timeline
Jan 1, 2011 → Aug 1, 2011
NCT ID
NCT01272934About Diclofenac Sodium
Diclofenac Sodium is a phase 3 stage product being developed by Novartis for Acute Ankle Sprain. The current trial status is completed. This product is registered under clinical trial identifier NCT01272934. Target conditions include Acute Ankle Sprain.
What happened to similar drugs?
20 of 20 similar drugs in Acute Ankle Sprain were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01272947 | Phase 3 | Completed |
| NCT01272934 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Ankle Sprain